BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  Aclaris Therapeutics to Participate in Two June Healthcare Investor Conferences

  Aclaris Therapeutics, Inc. today announced that members of the Aclaris management team will participate in two healthcare investor conferences in June.

  June 2, 2023

   · 

  1 min read
• Genetown

  Decibel Therapeutics to Participate in the Upcoming Jefferies Healthcare Conference

  Decibel Therapeutics today announced that Laurence Reid, Ph.D., Chief Executive Officer, will present a corporate overview at the Jefferies Healthcare Conference on Friday, June 9, 2023 at 12:45 p.m. E.T in New York, NY.

  June 2, 2023

   · 

  1 min read
• Drug Development

  Vigeo Therapeutics will present New Clinical and Immune Profiling Data from Ph I/II Expansion study in GBM Patients in ASCO Poster Oral Session

  Vigeo Therapeutics today announced new data from its Phase I/II expansion study evaluating single-agent activity of VT1021 in patients with recurrent glioblastoma (rGBM).

  June 2, 2023

   · 

  3 min read
• Drug Development

  Dragonfly Therapeutics to Present Phase 1 DF1001 Monotherapy Dose Escalation Results at ASCO 2023 Annual Meeting

  Dragonfly Therapeutics, Inc., a clinical stage biotechnology company developing novel immunotherapies, today announced an oral presentation of Phase 1 DF1001 Monotherapy Dose Escalation Results scheduled on Sunday June 4, from 11:45 - 11:57 a.m.

  June 2, 2023

   · 

  3 min read
• Numinus to Participate in a Water Tower Research Fireside Chat on Wednesday, June 7, 2023

  Numinus Wellness Inc. today announced that Payton Nyquvest , Founder and CEO, will participate in a Water Tower Research Fireside Chat on Wednesday, June 7, 2023, at 1:00 p.m. ET / 10:00 a.m. PT.

  June 2, 2023

   · 

  2 min read
• WELL Health to Participate at Eight Capital innoVIII: AI: Theory to Commerciality Conference

  WELL Health Technologies Corp. is pleased to announce that a team from WELL Health including Hamed Shahbazi , Founder and CEO, will be participating in the Eight Capital innoVIII: AI: Theory to Commerciality Conference (the “Conference”) in Montreal.

  June 2, 2023

   · 

  2 min read
• Can-Fite to Participate in Out-licensing and Distribution Partnering Meetings at Bio International Convention in Boston

  Can-Fite BioPharma Ltd. today announced its VP of Business Development, Dr. Sari Fishman, will participate in numerous partnering meetings at the Bio International Convention in Boston, Massachusetts on June 5-8, 2023.

  June 2, 2023

   · 

  5 min read
• Genetown

  Seres Therapeutics to Present at Jefferies Healthcare Conference

  Seres Therapeutics, Inc. today announced that Eric Shaff, President and Chief Executive Officer of Seres Therapeutics, will provide a corporate presentation at the Jefferies Healthcare Conference on Wednesday, June 7, 2023 at 8:00 a.m. ET in New York City.

  June 2, 2023

   · 

  1 min read
• Genetown

  Foundation Medicine Expands Monitoring Portfolio with Launch of FoundationOne®Monitor

  Foundation Medicine, Inc ., today announced the launch of its tissue-naïve circulating tumor DNA (ctDNA) monitoring assay, FoundationOne®Monitor, for research use in retrospective studies.

  June 2, 2023

   · 

  3 min read
• Genetown

  Aldeyra Therapeutics to Participate in Fireside Chat at the Jefferies Global Healthcare Conference - June 2, 2023

  Aldeyra Therapeutics to Participate in Fireside Chat at the Jefferies Global Healthcare Conference.

  June 2, 2023

   · 

  1 min read